Michelle Hilaire, interim dean of the College of Health Sciences, says the staff was proud of the UW WWAMI medical students’ ...
MORRISVILLE, N.C., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary ...
Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...
At the 2024 Educational Research and Innovations in Clinical and Health Sciences (ENRICH) Week poster session ... first place overall for an oral presentation at the UAB Heersink School of Medicine ...
KTAL Shreveport on MSN18d
LSU Health Shreveport showcases student research at Annual Fall Poster FairTuesday, LSU Health Shreveport's School of Medicine showcased their Summer research findings during their annual Fall poster ...
PharmaJet Poster Presentation at Cancer Immunotherapy Conference Highlights How Needle-free Technology is Enhancing Oncology ...
Si Fang. Poster presentation. Genetically proxied PCSK9 inhibition provides indications of lower prostate cancer risk: a Mendelian randomization study. Target Validation using Genomics and Informatics ...
Oral Poster Presentation Title ... hospitals and outpatient clinics for patients at risk for bleeding. A private medical technologies company, Perosphere is focused on development and ...
Philadelphia, Pennsylvania and Oxford, United Kingdom-- (Newsfile Corp. - November 5, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company working to redefine the treatment of solid tumor ...
A poster presentation at ASN Kidney Week 2024 showed data from the ... Selective Cytopheretic Device (SCD) QUELIMMUNE is the brand name of the SeaStar Medical’s SCD-PED. It was approved in February ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback